Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

January 06, 2010

ALISO VIEJO, Calif., Jan 06, 2010 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive officer, will make a presentation at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010 at 8:30 a.m. PST. The conference will be held at The Westin St. Francis Hotel in San Francisco.

A live webcast and audio archive will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL: http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink?ticker=VRX

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)

Contact:
Laurie Little
Valeant Pharmaceuticals
949-461-6002